Discover more from Courageous Discourse™ with Dr. Peter McCullough & John Leake
Spike Protein Linked to Alzheimer's Acceleration
SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation
During the last two years, several people in my broad social circle have told me that one or more of their parents seemed to experience a rapid cognitive decline during this time period. A British friend’s recent account is typical. On a trip home to visit her parents, she was stunned to learn that her father was just diagnosed with Alzheimer’s, as he’d seemed perfectly alert, engaged, and intellectually lively just two years ago. What could account for his precipitous decline? She confirmed that her father had received COVID-19 vaccines and multiple boosters since early 2021.
This anecdote was consistent with my general perception that the SARS-CoV-2 spike protein—to which our bodies are exposed from COVID-19 infection and COVID-19 vaccination and boosters—may be accelerating underlying, inflammatory disease processes such as arteriosclerosis and Alzheimer’s. In this scenario, a man who was destined to have a fatal heart attack at 74 due to his underlying arteriosclerosis has one at the age of 54 because the spike protein produced by the COVID-19 vaccine and boosters, has markedly accelerated the disease. A similar acceleration of the Alzheimer’s disease process of amyloid fibril formation in the brain struck me as plausible.
With my British friend’s anecdote fresh on my mind, I read with keen interest a paper—published on a preprint servicer by Larson, Hellstrand, et al. at Linkoeping University in Sweden—titled SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide.
Though the paper’s abstract only mentions COVID-19 infection as the cause of spike protein exposure, the full paper states the following:
Data from Brogna and colleagues demonstrate that Spike protein produced in the host as response to mRNA vaccine, as deduced by specific amino acid substitutions, persists in blood samples from 50% of vaccinated individuals for between 67 and 187 days after mRNA vaccination (23). Such prolonged Spike protein exposure has previously been hypothesized to stem from residual virus reservoirs, but evidently this can occur also as consequence of mRNA vaccination.
As Dr. McCullough frequently emphasizes, those who are at the greatest risk of developing disease syndromes caused by the SARS-CoV-2 spike protein are people who are repeatedly exposed to it through the vaccine, boosters, and infections. Because the COVID-19 vaccines do NOT prevent infection and may even impair natural immunity, those who continue to receive these shots are simply increasing their repeated exposure to the dangerous spike.